INNOVATION PHARMACEUTICALS INC. Deferred Tax Assets, Net of Valuation Allowance
INNOVATION PHARMACEUTICALS INC. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-09-28
- 2023-06-30: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2022-06-30: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2021-06-30: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2020-06-30: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2023-06-30 | $0.00 10-K · filed 2023-09-28 |
| 2022-06-30 | $0.00 10-K · filed 2023-09-28 |
| 2021-06-30 | $0.00 10-K · filed 2022-09-28 |
| 2020-06-30 | $0.00 10-K · filed 2021-09-27 |
| 2019-06-30 | $0.00 10-K · filed 2020-09-14 |